Skip to content

Study on the perioperative analgesic of suprascapular nerve block for arthroscopic shoulder surgery

Study on the perioperative analgesic of suprascapular nerve block for arthroscopic shoulder surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105667
Enrollment
Unknown
Registered
2025-07-08
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative pain after rotator cuff injury undergoing minimally invasive shoulder arthroscopic surgery

Interventions

Anterior suprascapular nerve block group:None
Upper main nerve block group:None
Posterior suprascapular nerve block group:None
Interscalene brachial plexus block group:None

Sponsors

Hebei Medical University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 25~75 years old who intend to undergo elective shoulder arthroscopic surgery under nerve block combined with general anesthesia, gender is not limited; 2.Understand the research and evaluation process, agree to participate in this trial, and voluntarily sign the informed consent form; 3.ASA Grading I.~II. 4.BMI 18~28 kg/m^2; 5.Blocking medication: posterior suprascapular nerve block, interscalene brachial plexus block, superior main nerve block, and 90 patients with anterior suprascapular nerve block were 0.375% ropivacaine 20ml, and 60 patients with anterior suprascapular nerve block were blocked with ropivacaine at different doses, concentrations and adjuvants.

Exclusion criteria

Exclusion criteria: 1.Patients with contraindications to nerve block before surgery; 2.Those who are allergic to local anesthetics; 3.Long-term use of analgesic drugs; 4.Severe visual or hearing impairment or are unable to communicate; 5.Transit incision; 6.Purulent inflammation of the soft tissues of the shoulder; 7.Pregnant or lactating; 8.Participated in other clinical trials within 1 month before being enrolled in the study.

Design outcomes

Primary

MeasureTime frame
Assessment of sensation blockage and motor blockage;NRS score and use of analgesics;perfusion index;Diaphragmatic mobility;

Secondary

MeasureTime frame
Patient satisfaction score;Postoperative adverse events;Successful assessment of nerve block;Blocking operation time, neural visualization status;Postoperative recovery quality score;Changes in MAP, HR, and SPO2;

Countries

China

Contacts

Public ContactXiuli Wang?

The Third Hospital of Hebei Medical University

wangxl301@aliyun.com+86 311 88602172

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026